DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Provera (Medroxyprogesterone) - Progesterone Receptor Assay Positive - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Progesterone Receptor Assay Positive ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Provera (Medroxyprogesterone) where reactions include progesterone receptor assay positive. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Provera side effects in female

Reported by a lawyer from United States on 2011-11-28

Patient: female, weighing 59.0 kg (129.7 pounds)

Reactions: Abdominal Pain, Pulmonary Hypertension, Lymphocyte Count Increased, FAT Embolism, Myocardial Ischaemia, Endoscopy Upper Gastrointestinal Tract, Chronic Obstructive Pulmonary Disease, Lumbar Spinal Stenosis, Metastatic Lymphoma, Hypoxia, Back Pain, Pain in Extremity, Breast Cancer Stage I, Breast Mass, Renal Cyst, Osteopenia, Hepatic Steatosis, Breast Cancer Stage II, Bone Densitometry, Breast Necrosis, Ultrasound Abdomen Abnormal, Pleural Fibrosis, Dyslipidaemia, Osteoporosis, Aortic Aneurysm, Gastritis, Dyspnoea Exertional, Interstitial Lung Disease, Basal Cell Carcinoma, Blood Cholesterol Increased, Malignant Melanoma, Oestrogen Receptor Assay Positive, Myocardial Infarction, Emphysema, Scoliosis, Dyspnoea, Nausea, Squamous Cell Carcinoma, Spondylolisthesis, Peripheral Vascular Disorder, Progesterone Receptor Assay Positive, Pulmonary Fibrosis, Osteoarthritis, Cardiac Failure, Nuclear Magnetic Resonance Imaging Abnormal, Spinal Osteoarthritis, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Medroxyprogesterone
    Indication: Hormone Replacement Therapy
    Start date: 1997-01-01
    End date: 2002-01-01

Prempro
    Dosage: .625/2.5 mg
    Administration route: Oral
    Indication: Osteoporosis Prophylaxis
    Start date: 1998-12-01
    End date: 2002-10-01

Estraderm
    Dosage: 0.05 mg, unk
    Indication: Osteoporosis Prophylaxis
    Start date: 1992-01-01
    End date: 1998-12-01

Provera
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Osteoporosis Prophylaxis
    Start date: 1992-01-01
    End date: 1998-12-01

Other drugs received by patient: Letairis; Calcium; Coumadin; Zocor; Advair Diskus 100 / 50; Boniva; Hydrochlorothiazide; Cozaar; Vitamin D; Spiriva; Celebrex; Viagra; Fosamax

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012